B
BrightInsight
The leading regulated Internet of Things platform for biopharma and medtech
About BrightInsight
BrightInsight is a startup that operates in the digital health market, offering a platform that expedites the development and launch of digital health products. Their services cater to a broad range of clients, including healthcare providers, medical device manufacturers, and pharmaceutical companies.
The company's primary function is to streamline the process of bringing digital health products to market. These products can range from mobile applications and healthcare provider interfaces to analytics dashboards, algorithms, and connected medical devices. BrightInsight also works with diagnostics and Software as a Medical Device (SaMD), a category of software applications that perform medical functions, across various therapeutic areas.
BrightInsight's business model is service-based. They generate revenue by providing their clients with the tools and support needed to develop and launch their digital health products more efficiently. For instance, they helped CSL Behring, a biotherapies provider, launch their B SUPPORT app in just four months.
In essence, BrightInsight is a digital health enabler, providing the necessary infrastructure and expertise to help their clients navigate the complex landscape of digital health product development and launch. Their value proposition lies in their ability to significantly reduce the time to market for these products, which can lead to cost savings and competitive advantages for their clients.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- San Jose, United States
- Employees
- 148
- Open positions
- None listed
- Dealroom signal
- 63.1/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Tech for Biotech and Pharma, Tech for Medical Professionals, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Technology
- IoT InternetOfThings
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jan 2026 | $0 | — | Eclipse Ventures · Insight Partners · General Catalyst · New Leaf Venture Partners | ↗ |
| SERIES COther financing | Mar 2021 | $101M | $750M | General Catalyst | — |
Growth signals
Latest recorded traffic for BrightInsight is 8.7K monthly website visits, up 38.1% over the last three months. BrightInsight's team declined 10.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
New Leaf Venture Partners
Eclipse Ventures
Insight Partners- PSPeter Sobiloff
Series B and later2 investors entered at this stage
General Catalyst
Mayo Clinic
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BrightInsight on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BrightInsight’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






